IMP
Process View
negative regulation of platelet derived growth factor receptor alpha signaling pathway
Any process that stops, prevents or reduces the frequency, rate or extent of platelet-derived growth factor receptor-alpha signaling pathway.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of platelet derived growth factor receptor alpha signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| C1qa | complement component 1, q subcomponent, alpha polypeptide | 1.000 | Mouse | |
| Tyrobp | TYRO protein tyrosine kinase binding protein | 0.933 | ||
| C1qc | complement component 1, q subcomponent, C chain | 0.431 | Mouse | |
| C1qb | complement component 1, q subcomponent, beta polypeptide | 0.207 | Mouse | |
| Csf1r | colony stimulating factor 1 receptor | 0.072 | ||
| Lyz1 | lysozyme 1 | 0.064 | ||
| Mrc1 | mannose receptor, C type 1 | 0.062 | ||
| Ctss | cathepsin S | 0.058 | ||
| Aif1 | allograft inflammatory factor 1 | 0.056 | ||
| Nrxn1 | neurexin I | 0.056 | ||
| Ly86 | lymphocyte antigen 86 | 0.054 | ||
| Emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 0.044 | ||
| Apoe | apolipoprotein E | 0.032 | ||
| Cd68 | CD68 antigen | 0.030 | ||
| Serping1 | serine (or cysteine) peptidase inhibitor, clade G, member 1 | 0.029 | ||
| Tmem176b | transmembrane protein 176B | 0.028 | ||
| Nos1 | nitric oxide synthase 1, neuronal | 0.027 | ||
| Folr2 | folate receptor 2 (fetal) | 0.025 | ||
| Lep | leptin | 0.025 | ||
| Grn | granulin | 0.022 | ||
| Ctsd | cathepsin D | 0.022 | ||
| Rpe65 | retinal pigment epithelium 65 | 0.022 | ||
| Mll2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 0.020 | ||
| C4b | complement component 4B (Childo blood group) | 0.019 | ||
| Hexa | hexosaminidase A | 0.019 | ||
| Tmem176a | transmembrane protein 176A | 0.017 | ||
| Ppyr1 | pancreatic polypeptide receptor 1 | 0.017 | ||
| Taf4a | TAF4A RNA polymerase II, TATA box binding protein (TBP)-associated factor | 0.016 | ||
| Pkn2 | protein kinase N2 | 0.015 | ||
| Pnpla2 | patatin-like phospholipase domain containing 2 | 0.015 | ||
| Kcnd3 | potassium voltage-gated channel, Shal-related family, member 3 | 0.015 | ||
| Lgmn | legumain | 0.015 | ||
| Tcfap2c | transcription factor AP-2, gamma | 0.014 | ||
| Cfp | complement factor properdin | 0.014 | ||
| C3 | complement component 3 | 0.014 | ||
| Ifitm3 | interferon induced transmembrane protein 3 | 0.014 | ||
| Bcl7a | B-cell CLL/lymphoma 7A | 0.014 | ||
| Scaf4 | SR-related CTD-associated factor 4 | 0.014 | ||
| Pparg | peroxisome proliferator activated receptor gamma | 0.014 | ||
| Ctsb | cathepsin B | 0.014 | ||
| Baz2a | bromodomain adjacent to zinc finger domain, 2A | 0.014 | ||
| Trpc5 | transient receptor potential cation channel, subfamily C, member 5 | 0.014 | ||
| Spen | SPEN homolog, transcriptional regulator (Drosophila) | 0.013 | ||
| Lrfn1 | leucine rich repeat and fibronectin type III domain containing 1 | 0.013 | ||
| Serpina3n | serine (or cysteine) peptidase inhibitor, clade A, member 3N | 0.013 | ||
| Cramp1l | Crm, cramped-like (Drosophila) | 0.013 | ||
| Fcgr3 | Fc receptor, IgG, low affinity III | 0.013 | ||
| Cfd | complement factor D (adipsin) | 0.012 | ||
| Doc2b | double C2, beta | 0.012 | ||
| Nkx1-2 | NK1 transcription factor related, locus 2 (Drosophila) | 0.012 | ||
| Grid2 | glutamate receptor, ionotropic, delta 2 | 0.012 | ||
| Calb2 | calbindin 2 | 0.011 | ||
| Drd2 | dopamine receptor D2 | 0.011 | ||
| Crtac1 | cartilage acidic protein 1 | 0.011 | ||
| Gucy2e | guanylate cyclase 2e | 0.011 | ||
| Gm505 | predicted gene 505 | 0.011 | ||
| Rnf44 | ring finger protein 44 | 0.011 | ||
| Wbp7 | WW domain binding protein 7 | 0.010 | ||
| Stab1 | stabilin 1 | 0.010 | ||
| P2ry6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 0.010 | ||
| Ctsh | cathepsin H | 0.010 | ||
| Car3 | carbonic anhydrase 3 | 0.010 | ||
| Sema5b | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B | 0.010 | ||
| Srrm1 | serine/arginine repetitive matrix 1 | 0.010 |